Four PhDs defended in 2022 from members of Molecular Oncology
Ina A. Eilertsen and Christian Holst Bergsland defended their respective work in transcriptomics and molecular pathology of colorectal cancer, Maren Høland recently defended her work on genomics of Malignant peripheral nerve sheath tumors, and Jonas Meier Strømme defended his computational analyses in solid tumors last week, 9th Dec. Their PhD theses comprise a total of thirteen papers from our groups, including eleven first-authorships among the PhD candidates.
Ina A. Eilertsen: "Tumor heterogeneity of gene expression and alternative splicing in primary colorectal cancer". Supervisors: Ragnhild A. Lothe and Anita Sveen. Evaluation committee: Jesper Bertram Bramsen, Aarhus University Hospital, DEN; Anthony Mathelier Centre for Molecular Medicine Norway, U of Oslo; Mette Kalager, Institute for Health and Society, U of Oslo
Christian Holst Bergsland: "Fluorescence-based multiplex immunohistochemistry in precision medicine of colorectal cancer". Supervisors: Ragnhild A. Lothe and Jarle Bruun. Evaluation committee: Manuel Salto-Tellez, ICR, London, GB; Lars A. Akslen, U of Bergen; Anne Hansen Ree, Institute for Clinical Medicine, U of Oslo
Maren Høland: "Molecular and clinical risk classification of malignant peripheral nerve sheath tumors" Supervisor: Ragnhild A. Lothe. Evaluation committee: Judith V.M.G. Bovee, Leiden University Medical Centre, NED; Marieke Kuijjer, Centre for Molecular Medicine Norway, U of Oslo; Øyvind Bruland, Institute for Clinical Medicine, U of Oslo
Jonas Meier Strømme: "Computational analyses of transcriptomic alterations in prostate and colorectal cancers". Supervisors: Rolf I Skotheim, Bjarne Johannessen and Torbjørn Rognes. Evaluation committee: Sampsa Hautaniemi, U of Helsinki, FIN; Christine Stansberg U of Bergen; Vera H. Goebel, U of Oslo